Inflammation is a known cardinal feature of T2D, which is marked by raised inflammatory biomarkers including the classic markers, e.g., IL-6, TNF-α, IL-1β, cytokines, and CRP, and the non-traditional ones, e.g., TREM-1 and uPAR [10]. The gene discussed is IL6; the disease is type 2 diabetes mellitus.